Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of FGEN will rise by +4.79% over the next 2 Weeks and hit $9.50 by Wednesday, January 21, 2026. In that time frame, FGEN's share price is expected to range between $9.09 and $9.91.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jan 21, 2026 | 8.69 | 9.16 | 9.63 |
| Jan 20, 2026 | 8.64 | 9.08 | 9.54 |
| Jan 19, 2026 | 8.75 | 9.21 | 9.63 |
| Jan 16, 2026 | 8.61 | 9.07 | 9.52 |
| Jan 15, 2026 | 8.44 | 8.88 | 9.34 |
| Jan 14, 2026 | 8.63 | 9.09 | 9.51 |
| Jan 13, 2026 | 8.54 | 9.01 | 9.46 |
| Jan 12, 2026 | 8.68 | 9.14 | 9.60 |
| Jan 9, 2026 | 8.51 | 9.00 | 9.47 |
| Jan 8, 2026 | 8.35 | 8.81 | 9.27 |
FGEN shares fell -1.63% in Monday, January 12, 2026's trading session, dropping from a previous close of $9.22 to move at $9.07. The stock demonstrated notable intraday movement (see FGEN's key stats for a full breakdown), fluctuating between $9.02 and $9.21, a +2.11% trading range. While recent weeks have seen some volatility, FGEN has managed to secure a +7.59% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 31.13K shares changing hands, 8.37K more than the previous session. This amounted to $282.30K in total market activity.
Will FGEN Continue Its Upward Trend?
According to analyst ratings and projections for FGEN, FibroGen, Inc. shares are anticipated to increase by +5.81%, potentially reaching $9.63 per share by January 21, 2026. Short-term technical indicators currently suggest a neutral sentiment for FGEN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the FGEN stock forecast, now is a good time to buy FGEN stock because its current trading price is -1.01% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on FGEN covering social and institutional perspectives.
FGEN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into FGEN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 42.97% to 43.90%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.94%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.87%, maintains a neutral outlook for the long term. Insights into FGEN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
FibroGen Short-Term Forecasts
FGEN Forecast For Next 5 Days
Our algorithm anticipates FibroGen (FGEN) stock could hit $6.76 by Jan 23, 2026. This represents a -25.50% rise from today's price, following a +11.61% change over the past five days.
FGEN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for FibroGen, Inc. (FGEN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $7.18, which would mean a -20.84% decrease from the current price of $9.07. Projections for this period range from a high of $8.46 to a low of $5.66.
FGEN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for FibroGen's price over the next three months point to a drop. FGEN stock is expected to peak at $10.60 on Jun 10, 2026 before potentially dipping to $0.00 on Jul 31, 2026. On average, FGEN is likely to trade around $2.38 in the coming 90 days.
FibroGen Stock Forecast 2025
Based on our predictive models, FibroGen (FGEN) is expected to trade between $0.00 and $12.34 throughout 2026. This would result in an average price of $2.11, potentially offering investors a -76.74% return from current levels.
FibroGen, Inc. Monthly Forecast 2026–2027
January 2026
According to our latest forecast models, FibroGen, Inc. (FGEN) is positioned to show a strong performance in January 2026. The price is predicted to move between $0.00 and $10.16, settling at an average of $2.58. This could translate to a -71.55% loss.
February 2026
Based on current market signals, FibroGen, Inc. is projected to trend february 2026. We forecast a trading range from $0.00 to $12.34, with a likely average price of $4.68. Investors could expect a potential return of -48.40%.
March 2026
Our predictive algorithms indicate FibroGen, Inc. stock may see a shift in March 2026. The expected range spans $0.00–$11.98, with an average target of $4.47. This represents a cautious outlook and a possible loss of -50.72%.
April 2026
Analyzing established trends, FibroGen, Inc. looks set to move in April 2026. Projections place the stock between $0.00 and $10.43, averaging around $3.22. This suggests a -64.50% loss from current levels.
May 2026
Market indicators suggest FibroGen, Inc. could experience notable changes during May 2026. Prices could fluctuate within $0.00 to $10.51, with a midpoint forecast of $3.36. The stock might deliver a -62.95% loss.
June 2026
Forecasting for June 2026, models estimate that FibroGen, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $10.60, averaging $2.69. This signals a cautious trajectory with potential returns around -70.34%.
July 2026
According to our latest forecast models, FibroGen, Inc. (FGEN) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $8.75, settling at an average of $1.24. This could translate to a -86.33% loss.
August 2026
Based on current market signals, FibroGen, Inc. is projected to trend august 2026. We forecast a trading range from $0.00 to $8.66, with a likely average price of $1.08. Investors could expect a potential return of -88.09%.
September 2026
Our predictive algorithms indicate FibroGen, Inc. stock may see a shift in September 2026. The expected range spans $0.00–$7.95, with an average target of $0.57. This represents a cautious outlook and a possible loss of -93.72%.
October 2026
Analyzing established trends, FibroGen, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $8.55, averaging around $0.78. This suggests a -91.40% loss from current levels.
November 2026
Market indicators suggest FibroGen, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $8.51, with a midpoint forecast of $0.32. The stock might deliver a -96.47% loss.
December 2026
Forecasting for December 2026, models estimate that FibroGen, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $8.02, averaging $0.87. This signals a cautious trajectory with potential returns around -90.41%.
January 2027
According to our latest forecast models, FibroGen, Inc. (FGEN) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $7.89, settling at an average of $0.96. This could translate to a -89.42% loss.
FGEN's history of dividends and stock splits also plays a role in long-term investor confidence.

